EUR 0.23
(-1.09%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.37 Million EUR | -25.17% |
2022 | 4.51 Million EUR | 31.76% |
2021 | 3.42 Million EUR | -11.46% |
2020 | 3.87 Million EUR | -32.9% |
2019 | 5.76 Million EUR | -11.98% |
2018 | 6.55 Million EUR | -5.74% |
2017 | 6.95 Million EUR | 9.42% |
2016 | 6.35 Million EUR | 18.43% |
2015 | 5.36 Million EUR | 41.98% |
2014 | 3.77 Million EUR | -6.17% |
2013 | 4.02 Million EUR | 20.35% |
2012 | 3.34 Million EUR | 23.97% |
2011 | 2.69 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 1.94 Million EUR | 0.0% |
2023 Q4 | 1.61 Million EUR | 0.0% |
2023 FY | 3.37 Million EUR | -25.17% |
2023 Q2 | 1.66 Million EUR | 0.0% |
2022 Q2 | 2.06 Million EUR | 0.0% |
2022 Q4 | 2.45 Million EUR | 0.0% |
2022 FY | 4.51 Million EUR | 31.76% |
2021 Q2 | 1.72 Million EUR | 0.0% |
2021 FY | 3.42 Million EUR | -11.46% |
2021 Q4 | 1.7 Million EUR | 0.0% |
2020 Q2 | 1.83 Million EUR | 0.0% |
2020 FY | 3.87 Million EUR | -32.9% |
2020 Q4 | 2.03 Million EUR | 0.0% |
2019 Q2 | 2.91 Million EUR | 0.0% |
2019 FY | 5.76 Million EUR | -11.98% |
2019 Q4 | 2.76 Million EUR | 0.0% |
2018 FY | 6.55 Million EUR | -5.74% |
2018 Q2 | 3.13 Million EUR | 0.0% |
2018 Q4 | 3.42 Million EUR | 0.0% |
2017 FY | 6.95 Million EUR | 9.42% |
2017 Q2 | 3.61 Million EUR | 0.0% |
2017 Q4 | 3.33 Million EUR | 0.0% |
2016 FY | 6.35 Million EUR | 18.43% |
2016 Q2 | 3.1 Million EUR | 0.0% |
2016 Q4 | 3.24 Million EUR | 0.0% |
2015 Q4 | 2.8 Million EUR | 0.0% |
2015 Q2 | 2.55 Million EUR | 0.0% |
2015 FY | 5.36 Million EUR | 41.98% |
2014 Q4 | 1.97 Million EUR | 0.0% |
2014 Q2 | 1.8 Million EUR | 0.0% |
2014 FY | 3.77 Million EUR | -6.17% |
2013 Q4 | 1.99 Million EUR | 0.0% |
2013 FY | 4.02 Million EUR | 20.35% |
2013 Q2 | 2.02 Million EUR | 0.0% |
2012 Q1 | 781.25 Thousand EUR | -0.0% |
2012 Q2 | 781.25 Thousand EUR | 0.0% |
2012 Q3 | 781.25 Thousand EUR | -0.0% |
2012 FY | 3.34 Million EUR | 23.97% |
2012 Q4 | 928.87 Thousand EUR | 18.9% |
2011 Q2 | 635.21 Thousand EUR | 0.0% |
2011 Q1 | 635.21 Thousand EUR | -0.0% |
2011 Q3 | 635.21 Thousand EUR | -0.0% |
2011 Q4 | 781.25 Thousand EUR | 22.99% |
2011 FY | 2.69 Million EUR | 0.0% |
2010 Q4 | 635.21 Thousand EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Affluent Medical SA | -1.2 Million EUR | 381.588% |
Bluelinea Société Anonyme | -3.84 Million EUR | 187.823% |
Carmat SA | -30.97 Million EUR | 110.91% |
Diagnostic Medical Systems S.A. | 15.84 Million EUR | 78.672% |
Euromedis Groupe | 3.57 Million EUR | 5.39% |
Eurobio Scientific Société anonyme | 53.96 Million EUR | 93.739% |
Ikonisys S.A. | 255.82 Thousand EUR | -1220.836% |
Implanet S.A. | 3.13 Million EUR | -7.888% |
Median Technologies SA | -2.55 Million EUR | 232.46% |
Theraclion SA | -1.08 Million EUR | 412.764% |
Euroapi S.A. | 164.6 Million EUR | 97.947% |
Guerbet SA | 197.14 Million EUR | 98.286% |
Ion Beam Applications SA | 134.44 Million EUR | 97.487% |
Koninklijke Philips N.V. | 7.44 Billion EUR | 99.955% |
Sequana Medical NV | 548.04 Thousand EUR | -516.561% |